ВАКЦИНАЦИЯ ПРОТИВ ВЕТРЯНОЙ ОСПЫ. ОТВЕЧАЕМ НА ВОПРОСЫ ПЕДИАТРОВ
Аннотация
Ключевые слова: ветряная оспа, профилактика, вакцинация.
(Вопросы современной педиатрии. 2009; 8(3):114-119)
Список литературы
1. Varis T., Vesikari T. Efficacy of a high-titre live attenuated varicella vaccine in healthy young children. J. Infect. Dis. 1996; 174 (Suppl. 3): 330−334.
2. Vesikari T., Baer M., Varis T., et al. Efficacy of varicella vaccine is dependent on the virus titre. 1st World Congress of Pediatric Infectious Diseases. Acupulco, Mexico. 4−7 December 1996. Abstract: 1996.
3. Miron D., Lavi I., Kitov R. et al. Vaccine eff ectiveness and severity of varicella among previously vaccinated children during outbreaks in day care centers with low vaccination coverage. Pediatr. Infect. Dis. J. 2005; 24 (3): 233–236.
4. Kreth H.W., Lee B.W., Kosuwon P. et al. Sixteen years of global experience with the first refrigerator-stable varicella vaccine (Varilrix). Biodrugs. 2008; 22 (6): 387–402.
5. Meurice F., De Bouver L., Vandevoorde D. et al. Immunogenicity and safety of a live attenuated varicella vaccine (Oka/SB Bio) in healthy children. J. Infect. Dis. 1996; 174 (Suppl. 3): 324−329.
6. Burgess M.A., Cossart Y.E., Wilkins T.D. et al. Varicella vaccination of health care workers. Vaccine. 1999; 17 (7-8): 765−769.
7. Ragozzino M.W., Melton L.J., Kurland L.T. et al. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982; 61 (5): 310–316.
8. Thomas S.L., Hall A.J. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect. Dis. 2004; 4 (1): 26–33.
9. Richards P. Shingles in one family practice. Arch. Fam. Med. 1996; 5 (1): 42–46.
10. Schmader K., George L.K., Burchett B.M. et al. Racial differences in the occurrence of herpes zoster. J. Infect. Dis. 1995; 171 (3): 701–704.
11. Donahue J.G., Choo P.W., Manson J.E., et al. The incidence of herpes zoster. Arch. Intern. Med. 1995; 155 (15): 1605–1609.
12. Mor M., Harel L., Kahan E., et al. Efficacy of postexposure immunization with live attenuated varicella vaccine in the household setting – a pilot study. Vaccine. 2004; 23 (3): 325–328.
13. Bekker V., Westerlaken G.H., Scherpbier H. et al. Varicella vaccination in HIV-1-infected children after immune reconstitution. AIDS. 2006; 20 (18): 2321-2329.
Рецензия
Для цитирования:
Таточенко В. ВАКЦИНАЦИЯ ПРОТИВ ВЕТРЯНОЙ ОСПЫ. ОТВЕЧАЕМ НА ВОПРОСЫ ПЕДИАТРОВ. Вопросы современной педиатрии. 2009;8(3):114-119.
For citation:
Tatochenko V. THE VACCINATION AGAINST VARICELLA. THE ANSWERS TO THE PEDIATRISTS QUESTIONS. Current Pediatrics. 2009;8(3):114-119.
Послать статью по эл. почте 
